Privia Health (PRVA) Cash from Financing Activities (2020 - 2026)

Privia Health's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$10.7 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 575.7% year-over-year to -$10.7 million in Q1 2026; TTM through Mar 2026 was -$6.2 million, a 201.79% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, up 54.64% from the prior year.
• Cash from Financing Activities slipped to -$10.7 million in Q1 2026 per PRVA's latest filing, from $2.1 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $8.6 million in Q3 2022 and bottomed at -$30.9 million in Q2 2022.
• The 5-year median for Cash from Financing Activities is $1.5 million (2023), against an average of -$918000.0.
• Across the five-year window, Cash from Financing Activities soared 9319.35% in 2022 and tumbled 575.7% in 2026, its largest moves.
• Year by year, Cash from Financing Activities stood at $2.0 million in 2022, then plunged by 97.85% to $42000.0 in 2023, then jumped by 1373.81% to $619000.0 in 2024, then jumped by 246.53% to $2.1 million in 2025, then sank by 597.44% to -$10.7 million in 2026.
• Per Business Quant, the three latest PRVA Cash from Financing Activities figures stand at -$10.7 million (Q1 2026), $2.1 million (Q4 2025), and $431000.0 (Q3 2025).